(19)
(11)
EP 0 755 262 A1
(12)
(43)
Date of publication:
29.01.1997
Bulletin 1997/05
(21)
Application number:
95913618.0
(22)
Date of filing:
07.03.1995
(51)
International Patent Classification (IPC):
C07D
205/
08
( . )
A61K
31/
397
( . )
A61K
31/
4427
( . )
A61K
31/
445
( . )
A61K
38/
00
( . )
A61P
9/
08
( . )
A61P
11/
00
( . )
A61P
11/
14
( . )
A61P
31/
04
( . )
C07D
401/
12
( . )
C07D
405/
06
( . )
A61K
31/
395
( . )
A61K
31/
40
( . )
A61K
31/
443
( . )
A61K
31/
495
( . )
A61K
38/
17
( . )
A61P
9/
10
( . )
A61P
11/
10
( . )
A61P
29/
00
( . )
A61P
33/
02
( . )
C07D
403/
12
( . )
(86)
International application number:
PCT/US1995/002938
(87)
International publication number:
WO 1995/024207
(
14.09.1995
Gazette 1995/39)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
(30)
Priority:
11.03.1994
US 19940212420
(71)
Applicant:
Merck & Co., Inc.
Rahway New Jersey 07065-0900 (US)
(72)
Inventor:
DAVIES, Philip
Rahway, NJ 07065 (US)
(74)
Representative:
Cole, William Gwyn, et al
European Patent Department Merck & Co., Inc. Terlings Park Eastwick Road
Harlow Essex CM20 2QR
Harlow Essex CM20 2QR (GB)
(54)
COMPOSITION FOR THE TREATMENT OF LUNG DISEASE